News
Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment ...
From concerning statistics on global health outcomes to new insights on AI and RWD, explore the top pharma news from July ...
Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...
Zacks Investment Research on MSN22h
AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs OutperformAstraZeneca’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks ...
The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback